Table of content for "Lisocabtagene car pos t" (HCPCS C9076)
General information on the “C9076” code
HCPCS Code: C9076
Long Description: Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Short Description: Lisocabtagene car pos t
Original information is taken from C9076 page
Pricing indicators
Pricing Indicator Code 1: 53 – Statute
Multiple Pricing Indicator Code A : Not applicable as HCPCS priced under one methodology
Certification and additional reference information
Coverage
Coverage: D – Special coverage instructions apply
Type of service
Berenson-Eggers Type of Service (BETOS): O1E – Other drugs
Type Of Service 1: 9 – Other medical items or services
Misc information
Anesthesia Base Unit Quantity: 0
Code Added Date: 20210701
Code Effective Date: 20211001
Termination Date: 20210930
Action Code: N – No maintenance for this code